Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 19, 2022

SELL
$1.2 - $3.62 $405,006 - $1.22 Million
-337,505 Closed
0 $0
Q1 2022

May 04, 2022

SELL
$2.96 - $8.8 $899,413 - $2.67 Million
-303,856 Reduced 47.38%
337,505 $1.28 Million
Q4 2021

Feb 03, 2022

BUY
$6.87 - $11.41 $4.41 Million - $7.32 Million
641,361 New
641,361 $4.41 Million

Others Institutions Holding SERA

About SERA PROGNOSTICS, INC.


  • Ticker SERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 29,596,900
  • Market Cap $165M
  • Description
  • Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...
More about SERA
Track This Portfolio

Track Oup Management Co., LLC Portfolio

Follow Oup Management Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oup Management Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oup Management Co., LLC with notifications on news.